Steven Cohen’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5K Buy
+11,868
New +$13.2K ﹤0.01% 3818
2023
Q4
– Sell
-6,674
Closed -$31.2K – 2442
2023
Q3
$31.2K Buy
6,674
+3,774
+130% +$20.8K ﹤0.01% 2215
2023
Q2
$15.5K Sell
2,900
-4,213
-59% -$34K ﹤0.01% 1839
2023
Q1
$70K Buy
+7,113
New +$121K ﹤0.01% 1707

Other funds holding INO

Steven Cohen's INO Position: Q3 2026 in Review

Steven Cohen opened a new position in Inovio Pharmaceuticals (INO) in Q3 2026: 11,868 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #3818 among its holdings. This is a return to the name: Steven Cohen previously reported a position in INO as recently as Q3 2023.

Steven Cohen first reported a position in INO in Q1 2023 and has held it in 4 quarters since. The position peaked at $70K in Q1 2023. 112 funds tracked by Wall St. Rank hold INO as of Q3 2026.

  • Steven Cohen held 11,868 shares of Inovio Pharmaceuticals worth $14.5K as of Q3 2026.
  • Inovio Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3818 holding.
  • Steven Cohen first reported a position in Inovio Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • Steven Cohen's Inovio Pharmaceuticals position peaked at $70K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.